220 related articles for article (PubMed ID: 33864025)
21. Carnosic acid attenuates RANKL-induced oxidative stress and osteoclastogenesis via induction of Nrf2 and suppression of NF-κB and MAPK signalling.
Thummuri D; Naidu VGM; Chaudhari P
J Mol Med (Berl); 2017 Oct; 95(10):1065-1076. PubMed ID: 28674855
[TBL] [Abstract][Full Text] [Related]
22. Urolithin B suppresses osteoclastogenesis via inhibiting RANKL-induced signalling pathways and attenuating ROS activities.
Qu Z; An H; Feng M; Huang W; Wang D; Zhang Z; Yan L
J Cell Mol Med; 2022 Aug; 26(16):4428-4439. PubMed ID: 35781786
[TBL] [Abstract][Full Text] [Related]
23. VSIG4 inhibits RANKL-induced osteoclastogenesis by enhancing Nrf2-dependent antioxidant response against reactive oxygen species production.
Miao J; Tu Y; Jiang J; Ren R; Wu Q; Liang H; Wang T; Lin B; Wu J; Pan Y; Wang X; Jin H
Int J Biol Macromol; 2024 Mar; 260(Pt 2):129357. PubMed ID: 38216011
[TBL] [Abstract][Full Text] [Related]
24. Antioxidants, like coenzyme Q10, selenite, and curcumin, inhibited osteoclast differentiation by suppressing reactive oxygen species generation.
Moon HJ; Ko WK; Han SW; Kim DS; Hwang YS; Park HK; Kwon IK
Biochem Biophys Res Commun; 2012 Feb; 418(2):247-53. PubMed ID: 22252298
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-1225 activates Keap1-Nrf2-HO-1 signalling to inhibit TNFα-induced osteoclastogenesis by mediating ROS generation.
Reziwan K; Sun D; Zhang B; Zhao Z
Cell Biochem Funct; 2019 Jun; 37(4):256-265. PubMed ID: 31017694
[TBL] [Abstract][Full Text] [Related]
26. Probucol suppresses osteoclastogenesis via activating Nrf2 signaling and ameliorates ovariectomy-induced bone loss.
Guo J; Ren R; Guo Z; Sun K; He J; Shao J; Wang X
Int Immunopharmacol; 2023 Mar; 116():109820. PubMed ID: 36758295
[TBL] [Abstract][Full Text] [Related]
27. Nrf2 activation attenuates both orthodontic tooth movement and relapse.
Kanzaki H; Shinohara F; Itohiya-Kasuya K; Ishikawa M; Nakamura Y
J Dent Res; 2015 Jun; 94(6):787-94. PubMed ID: 25795629
[TBL] [Abstract][Full Text] [Related]
28. β-Adrenergic signaling stimulates osteoclastogenesis via reactive oxygen species.
Kondo H; Takeuchi S; Togari A
Am J Physiol Endocrinol Metab; 2013 Mar; 304(5):E507-15. PubMed ID: 23169789
[TBL] [Abstract][Full Text] [Related]
29. Euphorbia factor L1 inhibits osteoclastogenesis by regulating cellular redox status and induces Fas-mediated apoptosis in osteoclast.
Hong SE; Lee J; Seo DH; In Lee H; Ri Park D; Lee GR; Jo YJ; Kim N; Kwon M; Shon H; Kyoung Seo E; Kim HS; Young Lee S; Jeong W
Free Radic Biol Med; 2017 Nov; 112():191-199. PubMed ID: 28774817
[TBL] [Abstract][Full Text] [Related]
30. Fisetin inhibits osteoclastogenesis through prevention of RANKL-induced ROS production by Nrf2-mediated up-regulation of phase II antioxidant enzymes.
Sakai E; Shimada-Sugawara M; Yamaguchi Y; Sakamoto H; Fumimoto R; Fukuma Y; Nishishita K; Okamoto K; Tsukuba T
J Pharmacol Sci; 2013; 121(4):288-98. PubMed ID: 23538677
[TBL] [Abstract][Full Text] [Related]
31. GSH attenuates RANKL-induced osteoclast formation in vitro and LPS-induced bone loss in vivo.
Han B; Geng H; Liu L; Wu Z; Wang Y
Biomed Pharmacother; 2020 Aug; 128():110305. PubMed ID: 32485573
[TBL] [Abstract][Full Text] [Related]
32. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J
Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759
[TBL] [Abstract][Full Text] [Related]
33. Tussilagone inhibits osteoclastogenesis by modulating mitochondrial function and ROS production involved Nrf2 activation.
Feng X; Liu Z; Su Y; Lian H; Gao Y; Zhao J; Xu J; Liu Q; Song F
Biochem Pharmacol; 2023 Dec; 218():115895. PubMed ID: 38084677
[TBL] [Abstract][Full Text] [Related]
34. Pseurotin A Inhibits Osteoclastogenesis and Prevents Ovariectomized-Induced Bone Loss by Suppressing Reactive Oxygen Species.
Chen K; Qiu P; Yuan Y; Zheng L; He J; Wang C; Guo Q; Kenny J; Liu Q; Zhao J; Chen J; Tickner J; Fan S; Lin X; Xu J
Theranostics; 2019; 9(6):1634-1650. PubMed ID: 31037128
[No Abstract] [Full Text] [Related]
35. Sodium hydrosulfide inhibits the differentiation of osteoclast progenitor cells via NRF2-dependent mechanism.
Gambari L; Lisignoli G; Cattini L; Manferdini C; Facchini A; Grassi F
Pharmacol Res; 2014 Sep; 87():99-112. PubMed ID: 24998607
[TBL] [Abstract][Full Text] [Related]
36. Dehydrocostus lactone inhibits NFATc1 via regulation of IKK, JNK, and Nrf2, thereby attenuating osteoclastogenesis.
Lee HI; Lee GR; Lee J; Kim N; Kwon M; Kim HJ; Kim NY; Park JH; Jeong W
BMB Rep; 2020 Apr; 53(4):218-222. PubMed ID: 31964469
[TBL] [Abstract][Full Text] [Related]
37. Nuclear Nrf2 induction by protein transduction attenuates osteoclastogenesis.
Kanzaki H; Shinohara F; Kajiya M; Fukaya S; Miyamoto Y; Nakamura Y
Free Radic Biol Med; 2014 Dec; 77():239-48. PubMed ID: 25224039
[TBL] [Abstract][Full Text] [Related]
38. Octyl itaconate inhibits osteoclastogenesis by suppressing Hrd1 and activating Nrf2 signaling.
Sun X; Zhang B; Pan X; Huang H; Xie Z; Ma Y; Hu B; Wang J; Chen Z; Shi P
FASEB J; 2019 Nov; 33(11):12929-12940. PubMed ID: 31490085
[TBL] [Abstract][Full Text] [Related]
39. Effects of deficiency of Kelch-like ECH-associated protein 1 on skeletal organization: a mechanism for diminished nuclear factor of activated T cells cytoplasmic 1 during osteoclastogenesis.
Sakai E; Morita M; Ohuchi M; Kido MA; Fukuma Y; Nishishita K; Okamoto K; Itoh K; Yamamoto M; Tsukuba T
FASEB J; 2017 Sep; 31(9):4011-4022. PubMed ID: 28515152
[TBL] [Abstract][Full Text] [Related]
40. Prolonged Cadmium Exposure and Osteoclastogenesis: A Mechanistic Mouse and
Liu Z; Wu J; Dong Z; Wang Y; Wang G; Chen C; Wang H; Yang Y; Sun Y; Yang M; Fu J; Li J; Zhang Q; Xu Y; Pi J
Environ Health Perspect; 2024 Jun; 132(6):67009. PubMed ID: 38896780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
